Virtual Tissues in Toxicology

New approaches are vital for efficiently evaluating human health risk of thousands of chemicals in commerce. In vitro models offer a high-throughput approach for assaying chemical-induced molecular and cellular changes; however, bridging these perturbations to in vivo effects across chemicals, dose, time, and species remains challenging. Technological advances in multiresolution imaging and multiscale simulation are making it feasible to reconstruct tissues in silico. In toxicology, these “virtual” tissues (VT) aim to predict histopathological outcomes from alterations of cellular phenotypes that are controlled by chemical-induced perturbations in molecular pathways. The behaviors of thousands of heterogeneous cells in tissues are simulated discretely using agent-based modeling (ABM), in which computational “agents” mimic cell interactions and cellular responses to the microenvironment. The behavior of agents is constrained by physical laws and biological rules derived from experimental evidence. VT extend compartmental physiologic models to simulate both acute insults as well as the chronic effects of low-dose exposure. Furthermore, agent behavior can encode the logic of signaling and genetic regulatory networks to evaluate the role of different pathways in chemical-induced injury. To extrapolate toxicity across species, chemicals, and doses, VT require four main components: (a) organization of prior knowledge on physiologic events to define the mechanistic rules for agent behavior, (b) knowledge on key chemical-induced molecular effects, including activation of stress sensors and changes in molecular pathways that alter the cellular phenotype, (c) multiresolution quantitative and qualitative analysis of histologic data to characterize and measure chemical-, dose-, and time-dependent physiologic events, and (d) multiscale, spatiotemporal simulation frameworks to effectively calibrate and evaluate VT using experimental data. This investigation presents the motivation, implementation, and application of VT with examples from hepatotoxicity and carcinogenesis.

[1]  Eric Bonabeau,et al.  Agent-based modeling: Methods and techniques for simulating human systems , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Phil McMinn,et al.  An integrated systems biology approach to understanding the rules of keratinocyte colony formation , 2007, Journal of The Royal Society Interface.

[3]  Jennifer Seed,et al.  A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.

[4]  Bilge Karaçali,et al.  Automated recognition of cell phenotypes in histology images based on membrane- and nuclei-targeting biomarkers , 2007, BMC Medical Imaging.

[5]  Christopher G. Chute,et al.  BioPortal: ontologies and integrated data resources at the click of a mouse , 2009, Nucleic Acids Res..

[6]  Hidde de Jong,et al.  Modeling and Simulation of Genetic Regulatory Systems: A Literature Review , 2002, J. Comput. Biol..

[7]  Jelena Pjesivac-Grbovic,et al.  A multiscale model for avascular tumor growth. , 2005, Biophysical journal.

[8]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[9]  P. Georgopoulos,et al.  Tissue-Level Modeling of Xenobiotic Metabolism in Liver: An Emerging Tool for Enabling Clinical Translational Research , 2022 .

[10]  Patrick Lambrix,et al.  Representations of molecular pathways: an evaluation of SBML, PSI MI and BioPAX , 2005, Bioinform..

[11]  Q. Su,et al.  Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia , 1997, Virchows Archiv.

[12]  F. Bruggeman,et al.  The nature of systems biology. , 2007, Trends in microbiology.

[13]  James A Glazier,et al.  Multicell simulations of development and disease using the CompuCell3D simulation environment. , 2009, Methods in molecular biology.

[14]  David M. Reif,et al.  Profiling Chemicals Based on Chronic Toxicity Results from the U.S. EPA ToxRef Database , 2008, Environmental health perspectives.

[15]  P Bannasch,et al.  Preneoplastic lesions as end points in carcinogenicity testing. II. Preneoplasia in various non-hepatic tissues. , 1986, Carcinogenesis.

[16]  J. Southgate,et al.  Agent-based computational modeling of wounded epithelial cell monolayers , 2004, IEEE Transactions on NanoBioscience.

[17]  R. Axelrod Reviews book & software , 2022 .

[18]  Maria Athelogou,et al.  Cognition Network Technology – A Novel Multimodal Image Analysis Technique for Automatic Identification and Quantification of Biological Image Contents , 2007 .

[19]  Hugh A Barton,et al.  Evaluation of physiologically based pharmacokinetic models for use in risk assessment , 2007, Journal of applied toxicology : JAT.

[20]  A. Brix,et al.  Comparative Hepatic Toxicity: Prechronic/Chronic Liver Toxicity in Rodents , 2005, Toxicologic pathology.

[21]  N. Van Rooijen,et al.  Effect of allyl alcohol on hepatic transporter expression: zonal patterns of expression and role of Kupffer cell function. , 2009, Toxicology and applied pharmacology.

[22]  A. Mclean,et al.  The Aging Liver , 1998, Clinical pharmacokinetics.

[23]  P. Hunter,et al.  Bioinformatics, multiscale modeling and the IUPS Physiome Project , 2008, Briefings Bioinform..

[24]  Andrew M. Colman,et al.  The complexity of cooperation: Agent-based models of competition and collaboration , 1998, Complex..

[25]  D. Dix,et al.  The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  S. L. Wong,et al.  A Map of the Interactome Network of the Metazoan C. elegans , 2004, Science.

[27]  K. Wake,et al.  Zonal and regional differences identified from precision mapping of vitamin a–storing lipid droplets of the hepatic stellate cells in pig liver: A novel concept of addressing the intralobular area of heterogeneity , 1998, Hepatology.

[28]  Nicolas Perry,et al.  Toward a multiscale model of antigen presentation in immunity , 2007, Immunological reviews.

[29]  P Bannasch,et al.  Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. , 1986, Carcinogenesis.

[30]  K. Porter,et al.  Structure of rat liver sinusoids and associated tissue spaces as revealed by scanning electron microscopy , 1974, Cell and Tissue Research.

[31]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[32]  P. Hunter,et al.  Using CellML in Computational Models of Multiscale Physiology , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.

[33]  Angelo Moretto,et al.  A Tiered Approach to Systemic Toxicity Testing for Agricultural Chemical Safety Assessment , 2006, Critical reviews in toxicology.

[34]  Ian Pate,et al.  Phenotypic Anchoring of Gene Expression Changes during Estrogen-Induced Uterine Growth , 2004, Environmental health perspectives.

[35]  Hiroaki Kitano,et al.  The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..

[36]  George P Daston,et al.  Gene expression, dose-response, and phenotypic anchoring: applications for toxicogenomics in risk assessment. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  Julio Saez-Rodriguez,et al.  Fuzzy Logic Analysis of Kinase Pathway Crosstalk in TNF/EGF/Insulin-Induced Signaling , 2007, PLoS Comput. Biol..

[38]  C. D. De Rosa,et al.  IMPLICATIONS OF CHEMICAL MIXTURES IN PUBLIC HEALTH PRACTICE , 2004, Journal of toxicology and environmental health. Part B, Critical reviews.

[39]  E. Wisse,et al.  Liver cell heterogeneity: functions of non-parenchymal cells. , 1992, Enzyme.

[40]  F. Collins,et al.  Transforming Environmental Health Protection , 2008, Science.

[41]  P D Karp,et al.  Pathway Databases: A Case Study in Computational Symbolic Theories , 2001, Science.

[42]  K. Sachs,et al.  Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data , 2005, Science.

[43]  H. Teutsch The modular microarchitecture of human liver , 2005, Hepatology.

[44]  Mike Holcombe,et al.  The Epitheliome Project: multiscale agent-based modeling of epithelial cells , 2006, 3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro, 2006..

[45]  I. Rusyn,et al.  WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. , 1998, Carcinogenesis.

[46]  S H Moolgavkar,et al.  The multistage theory of carcinogenesis and the age distribution of cancer in man. , 1978, Journal of the National Cancer Institute.

[47]  David Gavaghan,et al.  Multi-scale computational modelling in biology and physiology , 2007, Progress in Biophysics and Molecular Biology.

[48]  Andres Kriete,et al.  Combined histomorphometric and gene-expression profiling applied to toxicology , 2003, Genome Biology.

[49]  Jun'ichi Tsujii,et al.  Corpus annotation for mining biomedical events from literature , 2008, BMC Bioinformatics.

[50]  Patrick Hurban,et al.  Application of Visualization Tools to the Analysis of Histopathological Data Enhances Biological Insight and Interpretation , 2006, Toxicologic pathology.

[51]  A. Kriete,et al.  CIDE-A is expressed in liver of old mice and in type 2 diabetic mouse liver exhibiting steatosis , 2007, Comparative hepatology.

[52]  Thomas S Deisboeck,et al.  Emerging patterns in tumor systems: simulating the dynamics of multicellular clusters with an agent-based spatial agglomeration model. , 2002, Journal of theoretical biology.

[53]  David Gavaghan,et al.  Mathematical models in physiology , 2006, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[54]  R. Maronpot,et al.  New Insights into Functional Aspects of Liver Morphology , 2005, Toxicologic pathology.

[55]  Ivan Rusyn,et al.  Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[56]  J. Turner,et al.  Algorithms for automated characterization of cell populations in thick specimens from 3‐D confocal fluorescence microscopy data , 1994, Journal of microscopy.

[57]  E. Lobenhofer,et al.  Hepatic Transcript Levels for Genes Coding for Enzymes Associated with Xenobiotic Metabolism are Altered with Age , 2007, Toxicologic pathology.

[58]  Glen E. P. Ropella,et al.  In silico representation of the liver-connecting function to anatomy, physiology and heterogeneous microenvironments , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[59]  Francis Kiernan,et al.  The Anatomy and Physiology of the Liver , 1834, Edinburgh Medical and Surgical Journal.

[60]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[61]  Michael Wang,et al.  Automated image analysis technologies for biological 3D light microscopy , 1997, Int. J. Imaging Syst. Technol..

[62]  George Loizou,et al.  Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.